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Aims The present study sought to determine the relationship between left atrial (LA) volume (structural changes) and LA
function as assessed by strain rate imaging in patients with aortic stenosis (AS).
Methods
and results
The study consisted of a total of 64 consecutive patients with severe AS (,1 cm2) and 20 healthy control subjects.
The phasic LA volumes and function (tissue Doppler-derived strain) were assessed in all patients. As compared with
healthy controls, all strain-derived parameters of LA function were reduced in patients with AS. Conversely, only
indexed LA passive volume (increased) (7.6+ 3.8 vs. 10.5+5.1 ml/m
2
, P ¼ 0.02) and LA active fraction (decreased)
(43+6.7 vs. 31+13.3%, P, 0.001) (volume-based parameters) were significantly different between AS and con-
trols. In AS, LA volume-derived function parameters were poorly correlated with LA strain parameters. In fact, by
multivariable analysis, no LA phasic strain parameters emerged as independently associated with LA phasic volume
parameters.
Conclusions In AS, changes in LA function did not parallel changes in LA size. Furthermore, the increase in LA volume does not
necessarily reflect the presence of intrinsic LA dysfunction.
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Introduction
In aortic stenosis (AS), the chronically increased afterload is
accompanied by several structural and functional changes as pro-
gressive left atrial (LA) enlargement and dysfunction.1 In this situ-
ation, LA size may serve as a surrogate marker of chronic
diastolic function and left ventricular (LV) filling pressure,
whereas LA dysfunction may unmask the presence of an atrial
myopathic disease process.2,3 In severe AS, both LA dilatation
and dysfunction have been shown to adversely affect the
outcome. Assessing the relationship between LA size and function
is thus of clinical importance. LA function has three components:
reservoir, conduit and active functions. Reservoir function occurs
during LV systole, the conduit function results from the blood tran-
siting from the pulmonary veins into the LV during early diastole
and finally, the active contractile function arrives in late diastole
to increase LV filling.4–6 LA function has been initially described
by volumetric method in several diseases. In the recent years,
tissue Doppler-derived strain imaging has also been recognized
to adequately assess regional and global LA function in normal sub-
jects and in increased afterload states such as hypertension and
hypertrophic cardiomyopathy. In AS, whether LA structural
changes are accompanied by changes in LA function have not yet
been examined. The present study sought to (i) describe the
impact of AS on LA size and (ii) assess the relationship between




Between April 2008 and February 2010, LA volumes and function were
prospectively evaluated in 64 consecutive patients with AS (aortic
valve area ,1 cm2) and in 20 healthy control subjects. None of the
patients had concomitant significant valvular disease, chronic atrial
fibrillation or a pacemaker dependant rhythm. Calcific degenerative
AS was observed in 47 patients (73%), bicuspid valve was found in
16 patients (25%) and 1 patient (1.5%) had typical rheumatic
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involvement with commissural leaflet fusion. No history of coronary
artery disease, cerebrovascular disease, valvular abnormalities or dia-
betes was found in control subjects. Three subjects of the control
group had a well-controlled hypertension.
Echocardiographic measurements
Echocardiographic examinations were performed by using Vivid 7
ultrasound system (General Electric Healthcare, Little Chalfont, UK)
equipped with a 3.5 MHz variable frequency harmonic-phased array
transducer. Measurements of LV dimensions and LV mass were per-
formed by M-mode as recommended by the European Association
of Echocardiography. LV end-diastolic and end-systolic volumes and
ejection fraction were measured by the bi-apical Simpson method.
Continuous-wave Doppler was used to measure the aortic transvalv-
ular maximal velocities; peak and mean gradients were calculated
using the simplified Bernoulli equation. Aortic valve area was calculated
using the standard continuity equation.7,8 For each measurement, at
least three cardiac cycles were averaged. The LV diastolic function
was evaluated by the analysis of the mitral inflow velocities (E and A
waves). By using pulsed wave tissue Doppler, peak velocities during
systolic (Sa) early (Ea) and late (Aa) diastole obtained at the level of
septal, lateral, inferior and anterior mitral annulus were measured sep-
arately and then averaged. The E/A and E/Ea ratios were then
calculated.
Left atrial volumes
The following LA volumes were measured: (i) maximal LA volume or
Volmax, in ventricular systole just before mitral valve opening; (ii)
minimal LA volume or Volmin, after mitral valve closure and (iii) Volp,
just before the ‘P’ wave on ECG (Figure 1). All volumes were calculated
from the apical four- and two-chamber views using the Simpson
biplane method of discs. Special attention was paid to start/end
tracing at the mitral annulus and avoid pulmonary veins and auricle
in the tracings. LA stroke volume (LASV) was estimated as the differ-
ence between Volmax and Volmin. The LA ejection fraction (LAEF) was
calculated as (LASV/Volmax) × 100. Total LA volume is a composite of
three distinct phases of the LA function: the passive emptying volume,
the conduit volume and the active emptying volume. LA passive emp-
tying volume ¼ Volmax2 Volp; LA passive emptying fraction ¼ LA
passive emptying volume/Volmax. LA active volume ¼ Volp 2 Volmin;
LA active fraction ¼ LA active volume/Volp. Finally, LA conduit
volume ¼ LV stroke volume2 LASV. All volumes were indexed for
body surface area.9
Left atrial function: strain and strain rate
analysis
Colour-tissue Doppler imaging was performed in the apical four- and
two-chamber views with a narrow sector width at high frame rate
(≥150 /s). Careful attention was paid to align the atrial wall to the
Doppler beam. A sample volume of 10 × 2 mm was placed from
mid- to superior LA wall and tracked frame by frame to maintain its
position within the LA walls. For each measurement, at least two
end-expiratory cardiac cycles were averaged. Off-line peak strain and
strain rate were obtained at the level of septal, lateral, anterior and
inferior LA walls and then averaged to obtain global LA longitudinal
function. The myocardial strain profiles (St) were calculated by inte-
grating the strain rate over time and compensating for drift over the
cardiac cycle. As active atrial contraction occurs in diastole, the
strain curves were gated in diastole by moving the gating marker to
the end of the T wave on the ECG. For strain rate, the global peak sys-
tolic (SrS), early diastolic (SrE) and late diastolic (SrA) strain rate were
measured (Figure 1). During LV systole, LA acts as a reservoir, collect-
ing blood from the pulmonary veins while mitral valve is closed, and so
LA enlarges. Passive stretching of the LA walls, during LV systole leads
to LA longitudinal lengthening, which is recorded as a positive strain
rate (SrS) value. During early diastole, LA acts as a conduit for empty-
ing (SrE) and as a booster pump during atrial contraction (PSt and SrA)
in late diastole.4,6
The inter- and intra-observers variability for LA strain parameters
were previously reported by our group.4
Statistical analysis
Continuous variables are expressed as mean+ SD, unless otherwise
specified. Differences in continuous variables between groups were
assessed by Student t-test. Categorical variables were analysed by
the x2 test or Fisher exact test, as appropriate. Linear regression analy-
sis was applied to evaluate the correlation between variables. To
determine cofactors associated with parameters of LA function, a step-
wise multiple linear regression was performed. All variables that were
statistically significant univariately were entered in the model. The
selection of variables included in the multivariate model was per-
formed with a special care. To avoid colinearity among a subset of
several variables measuring the same phenomenon, we entered in
the multivariate models the variable that had the strongest association
with univariate analysis. Data were analysed using Statistica Software
(version 7).
Results
Characteristics of the population
Demographic and echocardiographic characteristics of the patients
are described in Table 1. As compared with healthy controls,
patients with AS were significantly older, had a higher prevalence
of coronary risk factors, and received more frequently an anti-
hypertensive treatment. Symptoms were reported by 20 patients
(31%) in the group of AS patients. Despite similar LV diameters
and ejection fraction, peak mitral Sa velocity as assessed by
tissue Doppler imaging was significantly reduced in patients with
AS compared with controls. The LV diastolic function was also
altered in AS. The mitral E velocity was increased while the Ea
and Aa were decreased. Consequently, E/Ea was significantly
higher in patients with AS.
Left atrial volumes and function
LA phasic volumes and function are depicted in Table 2. When
compared with controls, maximal, minimal, and pre ‘P’ volumes
were all significantly increased in patients with AS; 68% (n ¼ 42)
of them presented even a severe LA dilatation (indexed LA
volume ≥40 ml/m2). To note, LA enlargement was more pro-
nounced (P ¼ 0.01) in symptomatic patients with AS (Figure 2).
LASV was also significantly increased (P, 0.001) while LAEF
was more reduced in patients with AS (P, 0.001). With regard
to LA phasic parameters, LA passive volume was higher while
LA active fraction was lower in the AS group. Conversely, LA
passive fraction was similar in both groups. After adjustment for
age, differences between AS and control groups remained
similar, except for LAEF (Table 2).
In patients with AS and severe LA dilatation, LA passive and
active volumes were significantly increased while LA conduit
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volume was significantly reduced compared with controls
(Figure 3). Finally, regarding strain parameters, patients with AS
had a significant reduction of all strain and strain rate values com-
pared with the control group.
Correlations between left atrial phasic
volumes and function in controls and
aortic stenosis patients
Left atrial passive volume and fraction
In controls LA passive volume strongly correlated with age, peak
Ea velocity, indexed LA volmax and LAEF. Similarly, LA passive frac-
tion had a good correlation with age, peak Ea velocity and LAEF in
controls. In AS, LA passive volume was correlated with indexed LA
volmax and Doppler annular peak Sa velocities and inversely corre-
lated with global LA PSt (r ¼ 2 0.29, P, 0.05). LA passive fraction
was modestly correlated with LV systolic function parameters
(LVEF and peak systolic velocity), peak Ea velocity, E/Ea ratio and
LAEF in patients with severe AS. By multivariable regression,
after adjustment for age, both LA volmax (P, 0.001) and
Doppler annular peak systolic velocity (P ¼ 0.002) emerged as
independently associated with LA passive volume in AS (R2 ¼
0.37). To note, no parameter was independently associated with
LA passive fraction (Table 3).
Left atrial conduit volume
In controls, LA conduit volume was only correlated with indexed
LA volmax. In AS, LA conduit volume was correlated with aortic
valve area, LV ejection fraction, Doppler annular peak Sa velocity,
peak Ea velocity, peak Aa velocity, global LA SrS. There was also a
significant negative correlation between indexed LA volmax and LA
conduit volume in these patients. By multivariable analysis, after
adjustment for age, LV ejection fraction, peak Ea velocity, peak
Aa velocity and E/Ea ratio, both aortic valve area (P, 0.0001)
and indexed LA volmax (P, 0.0001) were independently associ-
ated with LA conduit volume in AS (R2 ¼ 0.62).
Left atrial active volume and fraction
In controls, LA active volume correlated with indexed LA volmax,
global LA PSt and global LA SrA. LA active fraction was greatly cor-
related with LAEF, global LA PSt and global LA SrA. In AS, LA
active fraction was correlated with LV ejection fraction, Doppler
annular peak Sa velocity, peak Aa velocity and LAEF. A negative
correlation was found between LA active fraction and mitral E
wave velocity and indexed LA volmax. LA active volume was not
correlated with global LA Pst and global LA SrA. There was a
modest negative correlation between LA active fraction and
global PSt and LA SrA. By multivariable analysis, after adjustment
for LV ejection fraction, mitral E wave velocity and indexed LA
volmax, peak Aa velocity was the sole parameter independently
Figure 1 Examples of measurement of left atrial volumes and tissue Doppler strain imaging in a four-chamber view in a patient with aortic
stenosis. (A) Left atrial volmax, (B) left atrialvolp, (C) left atrial volmin, (D) left atrial peak strain curves in septal and lateral left atrial walls, and (E)
left atrial strain rate curves in septal and left atrial lateral walls.
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associated with LA active fraction in AS (R2 ¼ 0.22, P ¼ 0.02). A
similar result was observed in controls (R2 ¼ 0.27, P ¼ 0.003).
Discussion
In AS, both the extent of LA remodelling and dysfunction markedly
affect the clinical outcome.4–13 From a mechanistic point, whether
the decrease in LA function is an epiphenomenon of the increased
LA size is unknown. The present study confirms and extends previous
reports by showing that both LA structural and functional changes are
common in AS.4,14 As compared with controls, volumes are increased
and function of the LA is depressed. However, although all strain-
derived parameters of LA function are declined, only indexed LA
passive volume (increased) and LA active fraction (decreased)
(volume-based parameters) are significantly different. Furthermore,
changes in LA function appear not to parallel changes in LA size in AS.
Left atrial volumes in aortic stenosis
Clinically, LA volume is most commonly expressed by the LA
volmax.
4–6,10 In AS, LA size increases with severity of valve stenosis
and worsening diastolic dysfunction and reflects the magnitude and
the chronicity of the increased LV filling pressure.8 In asymptomatic
patients with severe AS, LA size has been shown to be a powerful
prognostic marker.1,10 To note, after aortic valve replacement, LA
remodelling is also associated with clinical outcome.13 In the
present study, LA volmax was related to all atrial phasic volumes.
However, only LA passive volume (larger) and LA active fraction
(reduced) were significantly different as compared with controls.
In these patients, LA may achieve a maximal degree of expansion
during LV systolic period to progressively accommodate the elev-
ated LV filling pressures. To note, LA passive volume was even
larger in symptomatic patients. In these patients, the increase in
LA active emptying probably represents an ultimate compensatory
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Demographic, clinical and echocardiographic characteristics
Variables Controls (n 5 20) AS patients(n 5 64) P-value
Demographic data
Age (years) 54.9+7.9 71.4+13.0 ,0.001
Male [n (%)] 10 (50) 37 (58) NS
Heart rate (bpm) 75+12 71+11 NS
Body surface area (m2) 1.83+0.22 1.79+0.18 NS
Body mass index (kg/m2) 25.7+3.4 25.6+3.5 NS
Systolic blood pressure (mmHg) 135+20 141+25 NS
Diastolic blood pressure (mmHg) 78+11 74+12 NS
Clinical data
Coronary artery disease [n (%)] 0 23 (37) ,0.001
Hypertension [n (%)] 3 (15) 45 (63) ,0.001
Diabetes [n (%)] 0 17 (27) ,0.001
Dyslipidemia (n (%)] 6 (20) 36 (57) ,0.05
Smoking [n (%)] 4 (20) 11 (17) NS
Medication
ACE inhibitors [n (%)] 2 (10) 21 (33) ,0.05
Angiotensin receptor blocker [n (%)] 1 (5) 11 (17) ,0.05
Calcium channel blocker [n (%)] 0 9 (14) ,0.001
b-Blockers [n (%)] 1 (5) 31 (49) ,0.001
Diuretics [n (%)] 2 (10) 29 (46) ,0.01
LV systolic parameters
LV end-diastolic diameter (mm) 45.1+5.6 48.1+8.4 NS
LV ejection fraction (%) 64.4+6.5 62+13 NS
Peak mitral Sa velocity (cm/s) 9.5+2.2 6.1+1.6 ,0.001
LV diastolic parameters
Peak mitral E velocity (cm/s) 71.4+17.4 94.9+31.5 ,0.01
Peak mitral A velocity (cm/s) 78.2+20.9 89.5+31.4 NS
E/A ratio 0.96+0.28 1.2+0.61 NS
Mitral E deceleration time (ms) 180+47 225+91 ,0.05
Peak Ea velocity (cm/s) 11.2+2.6 6.8+2 ,0.001
Peak Aa velocity (cm/s) 12.5+1.6 8.9+2.6 ,0.001
E/Ea ratio 7.8+3.1 19.1+13.1 ,0.001
NS indicates non-significant; ACE, angiotensin-conversion enzyme and LV, left ventricle.
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mechanism to LA dilatation (Starling mechanism).15 In other
words, when cellular adaptation is exhausted, the increase in LV
filling pressure may increase LA wall tension and myocyte
stretch inducing myolysis, fibrosis, apoptosis and in turn LA
enlargement.1
Left atrial function in aortic stenosis
In AS, preserved LA function helps in maintaining optimal cardiac
output despite the impaired LV relaxation and reduced LV compli-
ance. Reduction of LA active function may thus favour clinical
deterioration, the occurrence of atrial fibrillation and alter the
spontaneous outcome.1,10,16 The accurate assessment of LA func-
tion is thus challenging. As for volumes, the different phases of LA
function (reservoir, conduit and active contractile functions) can be
adequately examined (tissue Doppler-derived strain imaging)
during the cardiac cycle.3,9 Contrary to LA phasic volumes, we
found that all three components of LA function (strain and strain
rate parameters) were reduced in AS, highlighting that the assess-
ment of LA function by volumetric method or strain imaging is not
equivalent. Indeed, the reduction in neither LA passive function—
global LA SrS—nor in LA conduit function—global LA SrE—was
related to the increase in LA passive volume or in LA conduit
volume. Moreover, LA active function (global LA SrA) was moder-
ately correlated with LA active fraction in AS. To note, this corre-
lation was stronger in controls, suggesting that in AS the decrease
in LA contraction does not purely parallel the increase in LA
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Left atrial volumes and function
Variables Controls (n5 20) AS patients (n5 64) P-value Age-adjusted
P-value
Indexed LA volmax (mL/m
2) 29+7.3 48.2+19.9 ,0.001 0.003
Indexed LA volmin (mL/m
2) 12.2+7.5 26.8+28.3 ,0.001 0.01
Indexed LA volp (mL/m
2) 21.4+6.3 37+18.3 ,0.001 0.02
Indexed LASV (mL/m2) 16.9+5.1 21.1+8.5 ,0.001 0.04
LAEF (%) 58.1+7.4 47.1+13.4 ,0.001 NS
Phasic LA volumes and function
Indexed LA passive vol (mL/m2) 7.6+3.8 10.5+5.1 0.02 0.01
LA passive fraction (%) 26.4+10.4 23.6+10.6 NS NS
Indexed LA conduit vol (mL/m2) 45.2+18.2 35.3+27.4 NS NS
Indexed LA active vol, mL/m2) 9.2+3.4 10.6+5.9 NS NS
LA active fraction (%) 43+6.7 31+13.3 ,0.001 0.02
Strain and SR parameters
Global LA SrS (s21) 2.43+0.73 1.66+0.58 ,0.001 0.012
Global LA SrE (s21) 22.31+0.89 21.5+0.61 ,0.001 0.016
Global LA SrA (s21) 23.17+0.65 22.3+0.94 ,0.001 0.017
Global LA PSt (%) 221.7+6.2 214.9+6.3 ,0.001 0.001
NS, non-significant; LA, left atrial; SV, stroke volume; LAEF, left atrial ejection fraction.
Figure 2 Indexed left atrial volmax of patients with aortic steno-
sis according to the presence of symptoms. LA indicates left atrial.
Figure 3 Left atrial phasic volumes in patients with or without
severe left atrial dilatation. †P, 0.01, *P, 0.05.
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volume. In our study, late diastolic mitral annular velocity (peak Aa
velocity) but not global LA SrA emerged as an independent par-
ameter associated with LA active fraction in both AS and controls.
Furthermore, although peak Aa velocity is reduced in AS, it
remains highly load dependent, which may limit its accuracy to
unmask the presence of LA dysfunction. Furthermore, it rather
reflects the displacement of the mitral annulus than intrinsic LA
function.1,17 Conversely, global LA SrA seems to be less affected
by loading conditions. LA SrA could represent a more accurate
parameter for evaluating the LA contractile function and identify
the presence of an atrial myopathic disease process.
Limitations
Patients with AS generally have other comorbidities, such as hyper-
tension or coronary artery disease, and often required multiple
medications. These factors may have a confounding impact on
our data. Nonetheless, this limitation does not affect the validity
of the main results of this study, which is the demonstration that
the increase in LA volume does not reflect the presence of intrinsic
LA dysfunction.
Evaluation of LA volume by echocardiography has some limit-
ations. Three-dimensional echocardiography and cardiac magnetic
resonance imaging can certainly improve the accuracy of the
assessment of LA size, but are not widely available. LA function
has been examined with tissue Doppler-derived strain imaging,
which is well known to be angle dependant. All care was taken
to ensure that tracking was in the LA wall and measurements per-
formed with an angle of interrogation ,308.
Conclusion
The LA phasic components can be assessed by both volume and
tissue Doppler-derived methods. In AS, however, LA volume-
based function parameters are poorly correlated with LA strain
parameters. Furthermore, the increase in LA volume does not
reflect the presence of intrinsic LA dysfunction.
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